Stock Price Quote

MESCO PHARMACEUTICALS LTD.

NSE : NABSE : 500274ISIN CODE : INE839X01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.540 (0 %)
PREV CLOSE ( ) 4.54
OPEN PRICE ( ) 4.54
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 700
TODAY'S LOW / HIGH ( )4.54 4.54
52 WK LOW / HIGH ( ) 4.544.54
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-08 1986
Management Info
- Chairman - Managing Director
Registered Office

Address Upper Kesalton,Tallital,,
Nainital,
Uttarakhand-263001

Phone 09871862796

Email nsparameswaran@mescosteel.com

Website www.mescopharma.com

Registrars Details
Skyline Financial Services Pvt Ltd
D-153/A, 1st Floor,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE

NEWS

12Nov Mesco Pharmaceuticals informs about ou
Mesco Pharmaceuticals has informed that the board at its meeting held on..
05Nov Mesco Pharmaceuticals to hold board me
Mesco Pharmaceuticals has informed that pursuant to Regulation 29 of the..
04May Mesco Pharmaceuticals submits RTA cert
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (..
22Jun Mesco Pharmaceuticals informs about ch
Mesco Pharmaceuticals has informed that Board of Directors had approved..
13Feb Mesco Pharmaceuticals informs about ou
Pursuant to Regulations 30 and 33 of SEBI (LODR) Regulations, 2015, Mesc..

Financials

in Millions
QTR Dec 21 ANNUAL 21
Net Profit-0.01-0.04
Gross Profit -0.01 -0.04
Operating Profit -0.01-0.04
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26946.00 (0.74%)
M.Cap ( in Cr)57258.37
Sanofi India (BSE)
peergroup  8118.25 (2.06%)
M.Cap ( in Cr)18696.83
Dr. Reddy's Lab (BSE)
peergroup  6155.15 (1.78%)
M.Cap ( in Cr)102679.14
Divi's Lab (BSE)
peergroup  3436.75 (2.14%)
M.Cap ( in Cr)91234.91
Glaxosmithkline Phar (BSE)
peergroup  1943.10 (3.26%)
M.Cap ( in Cr)32917.29

Shareholding Pattern

NON-INSTITUTION 60.7%
PROMOTERS 39.3%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Mesco Pharmaceuticals Ltd.

Mesco Pharmaceuticals Ltd. was incorporated in the year 1986. Its today's share price is 4.54. Its current market capitalisation stands at Rs 9.23 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Hawa Singh Chahar, Dushyant Kumar Singh, N S Parameswaran, Dhruv Singh.

It is listed on the BSE with a BSE Code of 500274 , NSE with an NSE Symbol of MESCOPHARM and ISIN of INE839X01015. It's Registered office is at Upper Kesalton,Tallital,Nainital-263001, Uttarakhand. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BS Subudhi & Co, N Dhawan & Co, Sangram Paul & Co, SN Dhawan & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.